Grass pollen sublingual immunotherapy combined with dupilumab inhibits allergen-induced nasal responses and specific IgE with an increase in specific IgG4: A randomised controlled trial

Authors
Category Primary study
ConferenceBritish Society for Allergy and Immunology 2026 Annual Conference
Year 2026
This article has no abstract
Epistemonikos ID: 3bc03b7fb9983e0e986d5b1f78acb63db6824219
First added on: Oct 24, 2026